Alan Krasner's Insider Trades & SAST Disclosures

Alan Krasner's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 1,687 Common Stock done at an average price of $17.1 . Disclosure was reported to the exchange on March 16, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 16 Mar 2023 1,687 42,301 (0%) 0% 17.1 28,881 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 01 Mar 2023 91,000 91,000 - - Common Stock (right to buy)
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 01 Mar 2023 19,500 43,988 (0%) 0% 0 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 31 Dec 2022 1,215 23,776 (0%) 0% 11.0 13,389 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 31 Dec 2022 712 24,488 (0%) 0% 11.0 7,846 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 28 Feb 2022 66,500 66,500 - - Common Stock (right to buy)
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 28 Feb 2022 14,250 22,561 (0%) 0% 0 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 19 Jan 2022 6,700 8,311 (0%) 0% 21.2 142,080 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 19 Jan 2022 6,700 160,473 - - Non-qualified stock option (Right to Buy)
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 19 Jan 2022 6,700 15,011 (0%) 0% 12.0 80,467 Common Stock
Crinetics Pharmaceuticals Inc
Alan Krasner Chief Medical Officer 26 Feb 2021 125,000 125,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades